Last reviewed · How we verify
NCT05718193
Real-Time Artificial Intelligence Assissted Colonoscopy to Identify and Classify Polyps
NA trial testing DeFrame in Artificial Intelligence in 2,868 participants. Completed in 15 March 2023.
28 February 2023
Quick facts
| Lead sponsor | Xiangya Hospital of Central South University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 2,868 |
| Start date | 1 June 2022 |
| Primary completion | 28 February 2023 |
| Estimated completion | 15 March 2023 |
| Sites | 2 locations across China |
Drugs / interventions tested
- DeFrame
- Classified DeFrame
- conventional colonoscopy
Conditions studied
- Artificial Intelligence — all drugs for Artificial Intelligence →
- Colonoscopy — all drugs for Colonoscopy →
- Quality Control — all drugs for Quality Control →
Sponsor
Xiangya Hospital of Central South University
Who can join
Adults 18 to 85, any sex, with Artificial Intelligence or Colonoscopy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the degree of the real-time detection and classification system for increasing the adenoma detection rate during colonoscopy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05718193
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of DeFrame
Trials testing the same drug.
- NCT05687318 — A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy · NA · completed
Other recruiting trials for Artificial Intelligence
Currently open trials in the same condition.
- NCT07257796 — Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score · recruiting
- NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
- NCT07261618 — AI-Assisted 2D Fetal Brain Ultrasound for Intracranial Anomaly Detection · active not recruiting
- NCT07098884 — Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos · recruiting
- NCT06978348 — Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology. · recruiting
Other Xiangya Hospital of Central South University trials
Trials by the same sponsor.
- NCT07482670 — Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases · not yet recruiting
- NCT07412223 — Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery · Phase 4 · not yet recruiting
- NCT07369960 — Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Glo · NA · recruiting
- NCT07369999 — Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke · Phase 3 · not yet recruiting
- NCT07309913 — China Atrial Fibrillation With Complex Metabolic Disorder Cohort Study (CAME Cohort) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05718193 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xiangya Hospital of Central South University
- Last refreshed: 11 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05718193.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing